Immunology and Microbiology
Acinetobacter Baumannii
21%
Aggregatibacter
21%
Antibiotic Sensitivity
42%
Antifungal Resistance
21%
Antimicrobial Resistance
21%
Aspergillus fumigatus
21%
Bacteroides fragilis
21%
Candida
37%
Candida Albicans
55%
Candida Glabrata
49%
Candida Krusei
21%
Candida Tropicalis
21%
Cardiobacterium
14%
Chlamydia Trachomatis
21%
Chlamydiae
21%
Cladistics
28%
Core Genome Multilocus Sequence Typing
19%
Desorption
28%
Disk Diffusion
8%
Dynamics
21%
Endocarditis
28%
Enterococcus
21%
Enterococcus faecalis
7%
Enterococcus faecium
73%
Epidemiological Data
25%
Escherichia coli
29%
Genome Sequencing
48%
Haemophilus
21%
Host Factor
10%
Inflammatory Disorder
21%
Kingella
14%
Klebsiella pneumoniae
46%
Lineages
21%
Matrix-Assisted Laser Desorption-Ionization
28%
Meningitis
28%
Microbiology
14%
Minimum Inhibitory Concentration
7%
Mortality Rate
26%
Multilocus Sequence Typing
100%
Pelvis
21%
Prevalence
49%
Sequenced Genomes
19%
Single Nucleotide Polymorphism
8%
Species Distribution
30%
Staphylococcus Aureus
10%
Streptococcus Group A
14%
Streptococcus pyogenes
21%
Time-of-Flight Mass Spectrometry
28%
Vancomycin-Resistant Enterococcus
67%
Whole Genome Sequencing
74%
Medicine and Dentistry
Acinetobacter Baumannii
21%
Amphotericin B
10%
Antifungal Agent
9%
Antifungal Therapy
21%
Aortic Valve Replacement
7%
Bacterial Meningitis
21%
Beta Hemolytic Streptococcus
21%
Beta-Lactamase
25%
Blood Culture
15%
Bloodstream Infection
28%
Candidemia
42%
Carbapenemase
25%
Cohort Analysis
23%
Cohort Effect
28%
COVID-19
7%
Diseases
26%
Drug Use
10%
Echinocandin
69%
Electronic Prescribing
7%
Empirical Treatment
7%
Enterococcus faecium
21%
Extended Spectrum Beta Lactamase
21%
Fluconazole
39%
Fungemia
64%
Genome Sequencing
21%
Glasgow Outcome Scale
6%
Group A Streptococcal Infection
21%
Hazard Ratio
7%
Heart Valve Prosthesis
21%
Hemolytic
9%
Infective Endocarditis
21%
Intensive Care Unit
7%
Itraconazole
10%
Klebsiella pneumoniae
21%
Meningitis
28%
Multilocus Sequence Typing
32%
Multiple Chronic Conditions
7%
Polymerase Chain Reaction
10%
Prevalence
7%
Primary Health Care
10%
Proportional Hazards Model
5%
Prosthetic Valve Endocarditis
7%
Prosthetics
7%
Species Distribution
9%
Staphylococcus Aureus
7%
Streptococcus Group A
16%
Streptococcus pyogenes
21%
Time-of-Flight Mass Spectrometry
21%
Vancomycin Resistant Enterococcus
19%
Whole Genome Sequencing
35%
Pharmacology, Toxicology and Pharmaceutical Science
Amphotericin B
10%
Antiinfective Agent
21%
Aspergillus fumigatus
21%
Bacterial Meningitis
21%
Beta Hemolytic Streptococcus
21%
Bloodstream Infection
7%
Candida
14%
Candida Albicans
18%
Candida Glabrata
18%
Candidemia
42%
Chlamydiae
21%
Chlamydiasis
21%
Cohort Study
23%
Diseases
26%
Echinocandin
48%
Enterococcus faecalis
13%
Enterococcus faecium
21%
Escherichia coli
8%
Fluconazole
26%
Fungemia
42%
Glasgow Outcome Scale
6%
Group A Streptococcal Infection
21%
Itraconazole
10%
Meningitis
28%
Multiple Chronic Conditions
7%
Pelvic Inflammatory Disease
21%
Prevalence
13%
Pyrrole
26%
Randomized Controlled Trial
6%
Staphylococcus Aureus
7%
Streptococcus Group A
16%
Streptococcus Pneumonia
8%
Streptococcus pyogenes
21%
Vancomycin
10%
Vancomycin-Resistant Enterococcus
10%
